Latest filing published 01 Oct 2010 for GTC BIOTHERAPEUTICS INC, €1,101.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Alan W. Tuck span 2 companies, the busiest being GTC Biotherapeutics Inc and Apogee Technology Inc. We count 20 filings; the first trade dates from 29 September 2006 and the latest from 30 September 2010.
The open-market side counts 2 purchases for €1,573 alongside 1 sale for €1,762. Sales outweigh purchases by €189. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 17 share grants.
On 1 October 2010 came the latest disclosure, a share grant for €1,101 in GTC Biotherapeutics Inc. The clock since the last published purchase (23 February 2007) now reads 7,182 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations